Table 2 Distribution of HPV infection status by age, ISUP group, and stage in this cohort
From: Genomic alterations related to HPV infection status in a cohort of Chinese prostate cancer patients
Characteristics | HPV-positive No. (%) | HPV-negative No. (%) | Total No |
|---|---|---|---|
| Â | 10 (16.9) | 49 (83.1) | 59 |
Age (yr) | Â | Â | Â |
 < 70 | 4 (26.7) | 11 (73.3) | 15 |
 ≥ 70 | 6 (13.6) | 38 (86.4) | 44 |
|  | P = 0.257 |  | |
ISUP group | Â | Â | Â |
 1 | 4 (36.4) | 7 (63.6) | 11 |
 2 | 2 (14.3) | 12 (85.7) | 14 |
 3 | 0 (0.0) | 13 (100.0) | 13 |
 4 | 2 (20.0) | 8 (80.0) | 10 |
 5 | 2 (18.2) | 9 (81.8) | 11 |
|  | P = 0.188 |  | |
T stage | Â | Â | Â |
 1 | 3 (60.0) | 2 (40.0) | 5 |
 2 | 3 (10.7) | 25 (89.3) | 28 |
 3 | 1 (6.3) | 15 (93.8) | 16 |
 4 | 3 (30.0) | 7 (70.0) | 10 |
|  | P = 0.024 |  | |
N stage | Â | Â | Â |
 0 | 7 (13.7) | 44 (86.3) | 51 |
 1 | 2 (40.0) | 3 (60.0) | 5 |
 X | 1 (33.3) | 2 (66.7) | 3 |
|  | P = 0.156 |  | |
M stage | Â | Â | Â |
 0 | 10 (17.2) | 48 (82.8) | 58 |
 1 | 0 (0.0) | 1 (100.0) | 1 |
|  | P = 1.000 |  | |